{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:23:34Z","timestamp":1792797814556,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023780","name":"School of Public Health, Portland State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.medj.2025.100841","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:55:15Z","timestamp":1757350515000},"page":"100841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dengue virus infection reprograms baseline innate immune gene expression"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-7058","authenticated-orcid":false,"given":"Eugenia Z.","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Xin","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara W.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin S.","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Y.L.","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan Rong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettie W.","family":"Kareko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe L.","family":"Lyski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vianney","family":"Tricou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansi","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Kalimuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny G.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuri","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0520-1544","authenticated-orcid":false,"given":"Eng Eong","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100841_bib1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","article-title":"Dengue","volume":"393","author":"Wilder-Smith","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100841_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fimmu.2014.00280","article-title":"Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections","volume":"5","author":"Grange","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib3","doi-asserted-by":"crossref","first-page":"e1074","DOI":"10.1093\/cid\/ciaa1840","article-title":"Higher Plasma Viremia in the Febrile Phase Is Associated With Adverse Dengue Outcomes Irrespective of Infecting Serotype or Host Immune Status: An Analysis of 5642 Vietnamese Cases","volume":"72","author":"Vuong","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medj.2025.100841_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jid.2017.10.018","article-title":"Interplay between Keratinocytes and Myeloid Cells Drives Dengue Virus Spread in Human Skin","volume":"138","author":"Duangkhae","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.medj.2025.100841_bib5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.humpath.2014.01.022","article-title":"Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar","volume":"45","author":"Aye","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.medj.2025.100841_bib6","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/s41590-023-01654-3","article-title":"Global and cell type-specific immunological hallmarks of severe dengue progression identified via a systems immunology approach","volume":"24","author":"Ghita","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib7","doi-asserted-by":"crossref","first-page":"S830","DOI":"10.1093\/clinids\/11.Supplement_4.S830","article-title":"Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade","volume":"11","author":"Halstead","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.medj.2025.100841_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.chom.2019.10.005","article-title":"Persistent Dengue Infection in an Immunosuppressed Patient Reveals the Roles of Humoral and Cellular Immune Responses in Virus Clearance","volume":"26","author":"Ng","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.medj.2025.100841_bib9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41577-019-0123-x","article-title":"Adaptive immune responses to primary and secondary dengue virus infections","volume":"19","author":"St John","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib10","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1080\/21645515.2020.1861875","article-title":"Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial","volume":"17","author":"Park","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.medj.2025.100841_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/infdis\/jiaa346","article-title":"Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue Vaccine","volume":"223","author":"Michlmayr","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medj.2025.100841_bib12","article-title":"Stimulation of B Cell Immunity in Flavivirus-Naive Individuals by the Tetravalent Live Attenuated Dengue Vaccine TV003","volume":"1","author":"Tu","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.medj.2025.100841_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009903","article-title":"Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine","volume":"18","author":"Izmirly","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.medj.2025.100841_bib14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ni.3178","article-title":"Innate immune memory: a paradigm shift in understanding host defense","volume":"16","author":"Netea","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib16","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1128\/JVI.77.21.11436-11447.2003","article-title":"Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development","volume":"77","author":"Huang","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.medj.2025.100841_bib17","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.vaccine.2019.11.061","article-title":"Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial","volume":"38","author":"Tricou","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.medj.2025.100841_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cid\/ciab864","article-title":"Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003)","volume":"75","author":"Rivera","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medj.2025.100841_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(17)30632-1","article-title":"Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study","volume":"18","author":"Saez-Llorens","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.medj.2025.100841_bib20","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1128\/JVI.02199-09","article-title":"Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections","volume":"84","author":"Jiang","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.medj.2025.100841_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109801","article-title":"Dengue virus is sensitive to inhibition prior to productive replication","volume":"37","author":"Talemi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.medj.2025.100841_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079518","article-title":"Protective roles of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in dengue virus infection of human lung epithelial cells","volume":"8","author":"Hsu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.medj.2025.100841_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.164","article-title":"Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity","volume":"1","author":"Chan","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.medj.2025.100841_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.medj.2025.100841_bib25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.smim.2014.09.006","article-title":"BCG-induced protection: effects on innate immune memory","volume":"26","author":"Netea","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12916-019-1292-y","article-title":"Repeated clinical malaria episodes are associated with modification of the immune system in children","volume":"17","author":"Bediako","year":"2019","journal-title":"BMC Med."},{"key":"10.1016\/j.medj.2025.100841_bib27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41586-022-05670-5","article-title":"Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19","volume":"614","author":"Sparks","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.medj.2025.100841_bib28","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1038\/s41467-021-22930-6","article-title":"Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model","volume":"12","author":"Hanley","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2025.100841_bib29","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(20)30556-0","article-title":"Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial","volume":"395","author":"Tricou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100841_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001643","article-title":"Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes","volume":"20","author":"Syenina","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.medj.2025.100841_bib31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.medj.2025.100841_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib34","article-title":"Insights into dengue immunity from vaccine trials","volume":"15","author":"Ooi","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.medj.2025.100841_bib35","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1128\/JVI.74.11.4957-4966.2000","article-title":"Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons","volume":"74","author":"Diamond","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.medj.2025.100841_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/viro.2001.1114","article-title":"Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism","volume":"289","author":"Diamond","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.medj.2025.100841_bib37","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100841_bib38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100841_bib39","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100841_bib40","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100841_bib41","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(20)30414-1","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial","volume":"395","author":"Biswal","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100841_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMoa2301790","article-title":"Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults","volume":"390","author":"Kall\u00e1s","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100841_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.it.2020.04.001","article-title":"Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?","volume":"41","author":"Tsang","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/intimm\/dxr123","article-title":"Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine","volume":"24","author":"Frasca","year":"2012","journal-title":"Int. Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2014.03.031","article-title":"Global analyses of human immune variation reveal baseline predictors of postvaccination responses","volume":"157","author":"Tsang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.medj.2025.100841_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002574","article-title":"Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines","volume":"3","author":"He","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.medj.2025.100841_bib47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41586-021-04060-7","article-title":"Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination","volume":"600","author":"Cho","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.medj.2025.100841_bib48","first-page":"311","article-title":"Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered","volume":"42","author":"Halstead","year":"1970","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.medj.2025.100841_bib49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.146.1.201","article-title":"Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody","volume":"146","author":"Halstead","year":"1977","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medj.2025.100841_bib50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fimmu.2014.00647","article-title":"Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity","volume":"5","author":"Schmid","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib51","doi-asserted-by":"crossref","first-page":"12982","DOI":"10.1128\/JVI.01224-10","article-title":"The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults","volume":"84","author":"Hoang","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.medj.2025.100841_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001887","article-title":"Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF","volume":"6","author":"Kumar","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.medj.2025.100841_bib53","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S1473-3099(20)30601-0","article-title":"Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis","volume":"21","author":"Sangkaew","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.medj.2025.100841_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2471\/BLT.07.040170","article-title":"Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control","volume":"86","author":"Egger","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.medj.2025.100841_bib55","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.1809253115","article-title":"Dynamics and determinants of the force of infection of dengue virus from 1994 to 2015 in Managua, Nicaragua","volume":"115","author":"Katzelnick","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2025.100841_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi1734","article-title":"Effects of boosting and waning in highly exposed populations on dengue epidemic dynamics","volume":"15","author":"Aogo","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.medj.2025.100841_bib57","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/jit273","article-title":"Reduced risk of disease during postsecondary dengue virus infections","volume":"208","author":"Olkowski","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medj.2025.100841_bib58","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1473-3099(14)70811-4","article-title":"Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study","volume":"14","author":"Osorio","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.medj.2025.100841_bib59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/vim.2008.0007","article-title":"Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses","volume":"21","author":"Roehrig","year":"2008","journal-title":"Viral Immunol."},{"key":"10.1016\/j.medj.2025.100841_bib60","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.medj.2025.100841_bib61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.medj.2025.100841_bib62","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12967-018-1578-4","article-title":"PBMC fixation and processing for Chromium single-cell RNA sequencing","volume":"16","author":"Chen","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.medj.2025.100841_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac377","article-title":"Self-supervised contrastive learning for integrative single cell RNA-seq data analysis","volume":"23","author":"Han","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.medj.2025.100841_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax9198","article-title":"A genome-wide transcriptomic analysis of protein-coding genes in human blood cells","volume":"366","author":"Uhlen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.medj.2025.100841_bib65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12864-020-07358-4","article-title":"Systematic comparison of high-throughput single-cell RNA-seq methods for immune cell profiling","volume":"22","author":"Yamawaki","year":"2021","journal-title":"BMC Genom."},{"key":"10.1016\/j.medj.2025.100841_bib66","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1038\/s41598-023-34163-2","article-title":"STAGEs: A web-based tool that integrates data visualization and pathway enrichment analysis for gene expression studies","volume":"13","author":"Koh","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.medj.2025.100841_bib67","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.medj.2025.100841_bib68","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12967-021-02936-w","article-title":"TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository","volume":"19","author":"Zhao","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.medj.2025.100841_bib69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-0716-0327-7_15","article-title":"In Silico Cell-Type Deconvolution Methods in Cancer Immunotherapy","volume":"2120","author":"Sturm","year":"2020","journal-title":"Methods Mol. Biol."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025002685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025002685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:44:25Z","timestamp":1773409465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634025002685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666634025002685"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100841","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dengue virus infection reprograms baseline innate immune gene expression","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100841"}}